LaCAR, a Belgian genetic diagnostics company, has strategically acquired Baebies' newborn screening department to expand its presence in the U.S. market and enhance its product portfolio.
Information on the Target
Arnaud Allaer is the CEO and founder of LaCAR, a genetic diagnostics company based in Liège, Belgium. Coming from a background steeped in entrepreneurship, particularly in the biotech sector—thanks to his father, Didier Allaer, founder of Diagenode—Arnaud is dedicated to creating impactful solutions that make a difference in people's lives. Upon graduating with a degree in commercial engineering from ULiège, he embarked on his entrepreneurial journey, seeking innovative projects, particularly those with a significant societal impact.
LaCAR began its journey with an initial investment of €50,000, targeting the adaptation of DNA-free analysis kits initially developed for plants and animals to human genetic diagnostics. Collaboration with esteemed professionals, including experts from CHU de Liège, helped to validate Arnaud's vision. Despite facing initial challenges where the company's plan did not proceed as anticipated, LaCAR eventually secured funding to establish a small laboratory and successfully developed its first two products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
Belgium's biotechnology sector is recognized for its innovation and rapid growth, with a focus on medical diagnostics and the development of novel therapeutic solutions. The country boasts numerous research institutions and uni
Similar Deals
Cochlear, Resmed, Nyxoah’s Chairman and Management → Nyxoah SA
2025
Fidelity Management & Research Company → Agomab Therapeutics NV
2023
LaCAR
invested in
ZenTech
in 2022
in a Other deal
Disclosed details
Revenue: $12M